financetom
Business
financetom
/
Business
/
Allegro Q1 revenue up 22%, beats expectations
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Allegro Q1 revenue up 22%, beats expectations
Jul 31, 2025 4:52 AM

Overview

* Allegro fiscal Q1 revenue rises 22% yr/yr, beating analyst expectations

* Non-GAAP EPS for fiscal Q1 increases nearly 3x, beating consensus

* Co made voluntary debt repayments of $35 mln in fiscal Q1

Outlook

* Company expects Q2 net sales between $205 mln and $215 mln

* Allegro projects Q2 non-GAAP EPS between $0.10 and $0.14

* Company anticipates Q2 gross margin of 48% to 50%

* Allegro foresees Q2 operating expenses around $73 mln

Result Drivers

* E-MOBILITY AND INDUSTRIAL GROWTH - Sales in e-Mobility and Industrial sectors increased 31% and 50% yr/yr, respectively

* OPERATING LEVERAGE - Non-GAAP EPS increased nearly 3x yr/yr, demonstrating significant operating leverage

* STRONG BOOKINGS - Co reports continued strong bookings and increasing backlog, contributing to positive momentum

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q1 Sales Beat $203.40 $197.80

mln mln (11

Analysts

)

Q1 Beat $0.09 $0.08

Adjusted (12

EPS Analysts

)

Q1 EPS -$0.07

Q1 Gross 44.9%

Margin

Q1 -1.3%

Operatin

g Margin

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the semiconductors peer group is "buy"

* Wall Street's median 12-month price target for Allegro Microsystems Inc ( ALGM ) is $37.50, about 9.7% above its July 30 closing price of $33.87

* The stock recently traded at 51 times the next 12-month earnings vs. a P/E of 49 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Summit Therapeutics' Lung Cancer Candidate Surpasses Merck's Multi-Billion Dollar Keytruda, Cuts Risk Of Disease Or Death By Half
Summit Therapeutics' Lung Cancer Candidate Surpasses Merck's Multi-Billion Dollar Keytruda, Cuts Risk Of Disease Or Death By Half
Sep 9, 2024
Sunday, Summit Therapeutics Inc. ( SMMT ) released data from the primary analysis of the Phase 3 HARMONi-2 trial of ivonescimab conducted in China, sponsored by collaboration partner Akeso, Inc. The data was presented at the International Association for the Study of Lung Cancer’s 2024 World Conference on Lung Cancer. The trial evaluated monotherapy ivonescimab against monotherapy Merck ( MRK...
UniFirst Opens Uniform Service, Processing Facility in London, Ontario
UniFirst Opens Uniform Service, Processing Facility in London, Ontario
Sep 9, 2024
07:56 AM EDT, 09/09/2024 (MT Newswires) -- UniFirst ( UNF ) said Monday that it opened its latest uniform service and processing facility in London, Ontario. The 56,000 square-foot-facility will serve about 2000 customers across Southwestern Ontario, providing services such as uniform and workwear rental, laundering, and maintenance. The facility has advanced processing technology to optimize the quality and efficiency...
Top Premarket Decliners
Top Premarket Decliners
Sep 9, 2024
07:56 AM EDT, 09/09/2024 (MT Newswires) -- Wheeler REIT (WHLR) shares slumped 23% pre-bell Monday, paring Friday's rally. C4 Therapeutics ( CCCC ) shares dropped 17%, adding to a 7.4% loss in the previous session. SmartKem ( SMTK ) shares were down 11%, reversing from Friday's gains. Price: 7.89, Change: -2.36, Percent Change: -23.02 ...
Teekay Launches $40 Million Buyback Program
Teekay Launches $40 Million Buyback Program
Sep 9, 2024
07:56 AM EDT, 09/09/2024 (MT Newswires) -- Teekay ( TK ) said Monday that its board has authorized a new share buyback program for the repurchase of up to $40 million common stock. The shipping company said it has nearly completed a previous $25 million repurchase program initiated in August 2022, buying back about 3.3 million shares at an average...
Copyright 2023-2026 - www.financetom.com All Rights Reserved